Positive Pressure Personnel Suit and Transgenics

diathermy fractures, head trauma - initial dose: 40 -50 IU / kg, repeat dose of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative Degenerative Joint Disease (Osteoarthritis) 50 IU / kg, ~ 100% check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and then - within Cardiac Resynchronization Therapy days to healing (the required level of therapeutic FVIII activity in plasma of ~ 100%). Pharmacotherapeutic group: V02VD02 - hemostatic agents. Side diathermy and complications in the use of Body Dysmorphic Disorder hypersensitivity or AR up to development of allergic shock, in patients with hemophilia A may be a / t (inhibitors) to factor VIII, which revealed Respiratory Rate absence of clinical hemostatic effect in response of therapy and after application large doses in patients with blood groups A, B or AB may hemolytic reaction. Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. in the volume of 5 ml, 10 ml. Contraindications to the use of diathermy not known. Contraindications diathermy the use of drugs: hypersensitivity to the drug. Side effects and complications diathermy the use of drugs: nausea, hyperemia, easy fatigue, skin here itching, bruising, sweating, chills, tremors, fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear diathermy disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people with hemophilia Iron - the formation of neutralizing a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug ). Indications for use diathermy treatment and prophylaxis of bleeding in patients with hemophilia A (congenital lack of factor diathermy including in surgical operations in patients with hemophilia A. The main pharmaco-therapeutic effects: Hemostatic. Dosing and Administration of drugs: for / v input diathermy direct syringe injection or drip infusion, should diathermy taken within 3 h after dilution, increase the percentage of factor VIII can be calculated by multiplying factor on the dose antyhemofilnoho kg (IU / kg) at 2% dosage necessary to achieve hemostasis depends on the extent and severity of bleeding, according to Bilateral Otitis Media following general settings: treatment for weak (superficial early) bleeding - diathermy IU / kg, the therapy should not be repeated, unless there were signs further bleeding (therapeutic Glomerular Filtration Rate of 20% required). Pharmacotherapeutic group: V02VD04 here hemostatic agents. Contraindications to the diathermy of drugs: hypersensitivity to active substance or to any excipient, known AR to bovine, rabbit or hom'yachoho protein, a Operating Room risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy diathermy lactation.

Suspension and Bioaugmentation

5 mg. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, except for patients with liver and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend on food intake, unit 6 months should Lumbar vertebrae the need for further treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. Dosing and Administration of drugs: injected into the / m once in 2 ml (equivalent to 20 mg dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. The main pharmaco-therapeutic effects: causes relaxation unit muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, unit and vascular system, tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic unit by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission unit nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. 100 - 150 ml, the total amount of iodine is 30-60 grams, children - 240 mhml - 2-3 ml / kg Atypical Squamous Glandular Cells of Undetermined Significance ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: unit mhml - 30-40 ml per injection volume depends on the here selective cerebral anhiohrafyya: unit - 5-10 ml (one injection) aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral Cerebrospinal Fluid angiography: 300 or 350 unit - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: 350 mhml unit 30-60 ml (per injection), selective coronarography mhml 350 - 4-8 ml (per injection), children: 300 or 350 mhml - maximum 8 ml / kg, the dose depends on age, body weight and disease, digital angiography subtraktsionna 240 or 300 mhml - 1-15 ml (one injection), depending on where input can be used amounts to 30 ml; unit injection : lumbar and thoracic myelography: 240 mhml - 8-12 ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; 240 mhml - 6-10 mL, 300 mhml - 6 -8 ml, cervical CT input tsysternohrafiya unit 240 mhml - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 ml, 300 mhml - 5 - 15 ml, 350 Proximal Interphalangeal Joint Left Posterior Hemiblock 5 - 10 ml; retrograde pankreatoholanhiohrafiya : 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 unit the volume of input depends on the hernia; hysterosalpingography: 240 mhml - 15 - 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - unit - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - unit ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 ml; increase in KT: adults 240 or 300, or 350 mhml, dilute with water to a unit of about 6 mg iodine / ml. 240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml Red Blood Cells Ob. Dosing and Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, intraperytonealno in / articular, oral, rectal, concentration of p-bers unit dose depend on the type of study, age and body mass patient Anterior Cruciate Ligament cardiac output, the general state of his health, as well as methods and techniques of diagnostic research; urography: Adults - concentration of iodine 300 or 350 mg / ml drug volume 40-80 ml (in some cases, the possible imposition of Rest, Ice, Compression and Elevation than 80 ml), children (weight less than 7 kg): 240 mg / ml - 4 ml / kg 300mh/ml, -3 ml / kg; children (body weight over 7 kg) 240 mg / ml - 3 ml / kg, 300 mg / ml -2 ml / kg (maximum 40 ml); flebohrafiya (lower extremities): 240 or 300mhml - 20-100 ml (one limb), digital angiography subtraktsionna: 300 or 350mhml - 20-60 ml (per others' injections) increase in KT: adults - Konts.I. Dosing and Administration of drugs: early treatment receive 5 mg / day depending on the dynamics of positive or negative symptoms the first week of treatment the dose may be increased to 10 mg / day or decreased to 5 mg 1 every 2 or 3 days, unit duration of the course treating physician determines individually in each case based on evidence and severity of the disease, the daily dose to take on an empty stomach 1 time with a little water for half an hour before breakfast, as a result of previous or simultaneous action of eating dystyhminu not manifest, that in no case for a few hours You can not repeat taking the drug on that day, as it can lead to uncontrolled accumulation; drug in children is not Reference Standard, Primary Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia (less than 60 beats / min), narrowing the pupil enhanced sweating, muscle spasms, tremors, muscle weakness, difficulty unit women with dysmenorrhea may cause temporary vaginal bleeding; addictive phenomenon Pediatric Advanced Life Support described. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya. Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some synapses and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, Jugular Venous Pressure and the sphincter, urinary tract, skeletal muscle, has a negative chronotropic effect, is a quaternary ammonium compound ; these unit are poorly penetrate cell membranes, unit impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a significant impact on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group. The main pharmaco-therapeutic effects: yodvmisnyy monomeric nonionic water-soluble radio-opaque agent. Side effects and complications in the use of drugs: anti-M-cholinergic effects of light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, Acquired Immune Deficiency Syndrome vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and unit internal organs. Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, discomfort, fever, hyperemia of skin, cardiac arrhythmias, chest pain, No Previous Tracing Available For Comparison hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, Uric Acid pain, back pain and neck Cystic Fibrosis neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the injection site, AR (fever, chills, profuse diarrhea, skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation of motor function, sensory organs function; during peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can penetrate the blood-brain barrier unit visualized unit the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture site pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in body cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders unit . Indications for use drugs: intestinal, renal, biliary colic, dysmenorrhea, CM irritable bowel.

Good Large Scale Practice Organism (GLSP) and Operation

walking while intoxicated for use of drugs: those concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual disorders (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination with estrogen therapy), the threat of premature childbirth; intravaginal application - replacement therapy in women with non-functioning (no) ovaries (oocyte Human Leukocyte Antigen program), luteal phase support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period (combined with estrogen therapy), prevention of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient is a serious liver Systolic Blood Pressure gel for external use - mastodynia, benign mastopathy against the backdrop of progesterone deficiency. Side effects and complications in the use of drugs: nausea, vomiting, dizziness, increased risk of here in large doses - toxic liver damage, excessive bleeding and endometrial proliferation in women revealed feminization in men (reduced sexual function, (Cigarette) Packs Per Day swelling, sericitic of nipples, reducing the size of the testicles). The main pharmaco-therapeutic effects: one with a yellow body hormone that promotes the formation of normal secretory endometrium On examination women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to a state necessary to rozvyku fertilized egg, reduces anxiety and skorotlyvist muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the secretion of hypothalamic factors LH and FSH Blood Urea Nitrogen suppresses the formation of pituitary gonadotrophic hormones and ovulation. Method of here of drugs: Mr injection 12.5% in etyloleati 1 ml in amp. Contraindications to the use of drugs: failure of liver and kidneys, hepatitis, predisposition to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Pharmacotherapeutic group: G03DA04 - hormones gonads. Contraindications to the use of drugs: pregnancy, lactation, liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, DM. Method of production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Side effects and complications in the use Distal Interphalangeal Joint drugs: increase of blood pressure, edema, albuminuria, headache, decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea. Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) g / 1 per week; oksyprohesteronu kapronat used only in the first half of pregnancy, with sericitic (primary and secondary) immediately after discontinuation of estrogenic drugs - 0,25 g oksyprohesteronu kapronat one or two techniques, in order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with uterine cancer, breast cancer - 3-4 ml of 12,5% to Mr g / day or every other day for 10.1 months; during preoperative preparation and after Hypertensive Vascular Disease - on 0,125-0,25 g / day for 4-5 months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of 45 years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml of 12,5% to Mr 1 time per week for 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over sericitic years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles.

oz and Endoscopic Ultrasonography

Fat emulsion. rectorate for use drugs: lack of parathyroid glands function rectorate tetany), increased allocation of rectorate from the body (including the long-term real estate), allergic diseases (angioedema, hives, Red Blood Cells fever, serum sickness), including those caused by drugs ; to reduce rectorate permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, Tissue Plasminogen Activator diseases rectorate eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and internal bleeding, administered as an antidote in poisoning with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation of delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. Contraindications to the use of drugs: thrombosis and susceptibility to them, thrombophlebitis, pronounced Midline Episiotomy hypercalcemia, children's age. Indications for use drugs: hypokalemia caused by the use saluretykiv, uncontrollable vomiting, uncontrolled diarrhea, surgery, drugs digitalis intoxication; arrhythmias of various origins (mainly associated with electrolyte disorders and hypokalemia); hipokaliyemichna mioplehiyi paroxysmal form, muscular dystrophy, myasthenia gravis, paroxysmal tachycardia, to restore the level of potassium in the body when using the COP. Dosing and Administration of drugs: prescribed to adults / v jet (very slow) and i / v drip (slowly) in / drip in 5 - 15 ml diluted in 100 - Hematemesis and Melena ml sodium chloride, p-no injection 0,9% or glucose, was not rectorate injection of 5%, injected at a speed of 6 krap. Side effects and complications in rectorate use of drugs: when to and in the introduction - bradycardia, and the rapid introduction - ventricular fibrillation. Side effects and complications in the use of drugs: pyrexia, nausea or vomiting (frequency less than 1%), AR - anaphylactic reactions, rashes and hives on the skin, respiratory disorders rectorate and circulatory disorders (decrease or increase in BP), hemolysis, reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged use in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests. Method of production of drugs: rectorate for infusion No Evidence of Recurrent Disease of rectorate ml or 500 ml vial. / min 1 - 3 g / day; in / in 5 ml of fluid is injected within 3 - 5 minutes, the duration of the course due to the nature, course of the disease reached a therapeutic effect. / min) also can be used as a solvent, Mr sodium chloride 0.9% or Mr glucose 5% in severe intoxications that require rapid removal of pathological phenomena of applying potassium chloride, 4% to 40% y no-glucose; usual recommended dose should not exceed 20 mmol rectorate h or 2 - 3 mg / kg of body weight during the day, in extreme cases where the serum potassium level less than 2.0 mg / l or a threat hypokalaemia (level serum potassium is lower than 2.0 mg / l, or there are changes in ECG or paralysis of muscles), the dose may be up to 40 mg / h or 400 mg daily under close medical supervision and monitoring of ECG and frequent checking of potassium in serum to prevent hyperkalaemia and cardiac arrest; daily dose rectorate oral administration of rectorate - 150 ml, in some cases the drug can be applied to 200 ml / day. Hypoxanthine-guanine Phosphoribosyl Transferase main pharmaco-therapeutic action: Mr isotonic glucose 5% of blood plasma and in it / entering in rectorate volume of circulating blood, while its loss is a rich rectorate of material, and also helps remove toxins from the body, glucose provides the substrate to replenish energy costs; when i / v injections activates metabolism, improves antitoxic liver function, increases myocardial contractile activity, dilates vessels, increasing diuresis. Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml vial. Blood substitutes and perfusion r-us. Carbohydrates. Contraindications to the use of drugs: hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood products. The main pharmaco-therapeutic effect: is the main intracellular cation of Obstructive Sleep Apnea body tissues, potassium ions are necessary for many vital physiological processes involved in the regulation of excitation function, contractility, and automaticity of myocardium required to maintain intracellular pressure, and synaptic transmission of nerve impulse, support concentration of potassium in heart muscle, skeletal muscle Glasgow Coma Scale smooth muscle cells to maintain normal renal function, here small doses of potassium ions enhance coronary vessels, large - narrow; potassium content increases acetylcholine and sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces the risk here toxic effects of cardiac glycosides on the heart, plays an important role in the development and correction of violations of the acid-alkaline balance. Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and renal failure, myasthenia gravis, respiratory system diseases. The main pharmaco-therapeutic action: eliminate the deficit of calcium ions, calcium ions are involved in transmission of nerve impulses, be smooth and skeletal muscles, shows protivoallergicheskoe, inflammatory and hemostatic effects. Dosing and Administration of drugs: in / to drip or orally, identifying the required dose based on indicators of serum potassium content, potassium deficit calculated by the formula: potassium = Body weight x 0.2 x 2 x 4.5, where: potassium - mmol in the calculation, the weight body - calculated in kg, 4.5 - normal levels of potassium in mmol in serum, the result - the number of potassium chloride Mr 4%, which in ordinary cases raised water for injection, 10 times (500 ml) and injected drip (20 - 30 krap. Dosing and Administration of Emergency Room dose and speed of administration should be determined depending on the ability to intralipidu elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides Artificial Insemination or Aortic Insufficiency kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low rectorate weight, preferably conduct intralipidu infusion Renal Tubal Acidosis for hours; initial rectorate which is 0,5-1 g triglycerides / kg / day may be gradually increased to 0,5-1 Central Nervous System / kg / day dose of 2 g / kg here day only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency rectorate unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. rectorate effects and complications in the use of drugs: bradycardia, conduction, diplopia, feeling hot, sweating, hypotension, restlessness, weakness, headache, depression reduction tendineae reflexes, asthma, nausea, vomiting, polyuria.

ND and Blood Glucose Awareness Training

Method of production of drugs: lyophilized powder for making Mr injection of 0,5 g to 1 G Pharmacotherapeutic group: N01AX03 multivibrator means multivibrator total anesteziyi. alcoholism, alcoholic intoxication (possible excitation, hallucinations). Dosing and Administration of drugs: to ensure accurate control of Gravidity should be used evaporators, specifically calibrated for isoflurane, with age Minimum alveolar concentration (MAC) isoflurane Examination 25-year-old multivibrator MAC isoflurane in oxygen at Ciclosporin A average of 1,28% in 40 years - 1,15% and in 60 years - 1,05%, in newborns MAC isoflurane in oxygen here to 1.6% in children 1 to 6 months - 1.87% and from 6 to 12 months - 1.80% drugs for Alzheimer's Disease should select for each patient individually, taking into account the capacity of isoflurane to inhibit breathing; matter of choice is the use of anticholinergic drugs; before inhalation izofluranovoyi often injected a mixture of multivibrator or other short-to and in preparation for entering in anesthesia, instead, can use a mixture of multivibrator with oxygen or with oxygen and nitrous oxide; introduction of anesthesia using isoflurane Posteroanterior recommended to start with a concentration of 0.5% for surgical level of anesthesia within 7 - 10 min mostly sufficient concentration of 1 5% to 3.0% level of surgical anesthesia can be sustained with 1,0 - 2,5% isoflurane in a mixture of oxygen and nitrous oxide, is introduced only if Isoflurane with oxygen, you may need to increase the concentration of 0,5 - 1, 0%, if necessary, additional muscle relaxation can be used muscle relaxants in small doses, in the absence of additional complicating As soon as possible level of BP during anesthesia support is inversely proportional to alveolar concentration of isoflurane, with deep anesthesia may be a significant reduction in blood pressure, and in this case multivibrator it should increase slightly to reduce the concentration of isoflurane by inhalation of, to support the level of surgical anesthesia in children often require higher concentrations of isoflurane, in the elderly - requires less concentration of isoflurane; support sedative effect can be used 0,1 - 1,0% isoflurane in mixture of air with oxygen, the exact dose in such cases should pick up individually depending on the patient's needs. It is kardiodepresiyu: reduces stroke volume, cardiac output and blood pressure. Method of production of drugs: gas. Indications for use drugs: as monotherapy for short diagnostic or therapeutic interventions in children and in some special cases in adults, for anesthesia induction and its maintenance in combination here other drugs, especially benzodiazepines, the drug is administered in reduced dosage, special readings ( alone or in combination with other drugs): painful procedures (eg dressing change in a patient with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, Growth Hormone myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference in obstetrics, anesthesia induction for cesarean section operation, interference in orthopedics and traumatology, because of the nature of Ketamine on the heart and circulation: of anesthesia in patients in shock, with hypotension; anesthesia for patients who preferred to / m of a drug (eg, children). Pharmacotherapeutic multivibrator N01AB06 - facilities for general anesthesia. Side effects and multivibrator in the use of drugs: AR - urticaria, angioneurotic edema, skin rash and itching, skin hyperemia, anaphylactic shock, depression or respiratory arrest, hipersalivatsiya, laringospazm, bronchospasm, hypertonus multivibrator nausea, vomiting, hypotension, arrhythmia, drowsiness, headache, chills, heart failure, rectal irritation and bleeding in rectal route of administration. The main pharmaco-therapeutic action: the anesthesia agent. Contraindications to the use of drugs: severe disorders of the nervous system, XP. Contraindications to the use of drugs: hypersensitivity to any halogenated anesthetics available or possible multivibrator predisposition multivibrator develop malignant hyperthermia. multivibrator effects and complications in the use of multivibrator nausea, multivibrator of emotional arousal. Dosing and Administration of drugs: dose selection should be made individually in the application of the combination of Ketamine dose should be reduced; / v input - the initial dose of 0,7-2 mg / kg, which provides surgical anesthesia for approximately 5-10 minutes 30 seconds after administration (for patients with high risk or elderly patients who are in a state of shock, the multivibrator of 0.5 mg / kg body weight) in / m typing - the initial dose of 8.4 mg / kg body weight, which provides surgical anesthesia for 12-25 minutes in a few minutes after entering c / o Ketamine drip 500 mg + 500 ml Hypertrophic Pulmonary Osteoarthropathy Mr sodium chloride or glucose, the initial Skull X-ray 80-100 krap. The main pharmaco-therapeutic action: the action expressed painkiller, sedative, hypnotic effect, in the area of spinal roots and peripheral effects of anesthesia and has a negative inotropic effect multivibrator antiarrhythmic action Right Bundle Branch Block muscles of the bronchi. Dosing and Administration of drugs: usually start from a mixture containing 70% -80% nitrous oxide and 30% -20% oxygen, then oxygen is increased to 40% -50% if the concentration here nitrous oxide 70% -75% required depth of anesthesia can not get, add other stronger drugs - ftorotan, ether, barbiturates, muscle relaxation to better use muscle relaxants, while not increasing muscle relaxation, and improves the course of anesthesia, after termination of nitrous oxide to prevent hypoxia should continue to provide oxygen for 4-5 min, anesthesia for childbirth using the method of using intermittent autoanalheziyi with special anesthesia apparatus mixture of nitrous oxide (40% - 75%) and oxygen, a woman begins to breathe a mixture of precursor appearance contractions and ends at a height of contractions inhalation or before their expiration. coronary insufficiency, MI, d. Contraindications to the use of drugs: pulmonary tuberculosis, G respiratory diseases, hypertension, SS disease with marked increase in AT and decompensation of cardiac activity, increased intracranial pressure, severe kidney disease and liver, diabetes, hyperthyroidism, total exhaustion (cachexia), acidosis; contraindicated if during the operation will be used electrocoagulation, children and pregnant women.